Outer Biosciences has raised $23.0M, a fresh infusion of capital aimed at unlocking the therapeutic potential of nature’s less-traveled corners. The company is betting that the path to better human health runs through bioactive compounds found in sources science has largely overlooked.
What sets Outer apart is its toolkit: a platform built on clinically relevant, long-lasting models of human skin, paired with multimodal data analysis and predictive machine learning. That combination lets the company screen for safe, efficacious bioactives at a scale that’s hard to match, with an eye toward health and beauty products. The vision is ambitious-using evidence to show that nature, properly decoded, can heal. The round gives Outer the runway to keep pushing that thesis forward.
